| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2025 | SANTE QUEBEC CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 SAINT-DENIS STREET | MONTREAL | QC | | | CAN | R01EY036865 | Interpericyte tunneling nanotubes as new therapeutic targets for neurovascular recovery and vision restoration in glaucoma. | 000 | 1 | NIH | 9/9/2026 | $0 |
| | 2026 | 2024 | SANTE QUEBEC CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 SAINT-DENIS STREET | MONTREAL | QC | | | CAN | R01AG054324 | Role of IL-32 as a predictor and mediator of Premature Aging Phenotypes(PAP) in HIV infection. | 000 | 8 | NIH | 4/9/2026 | $0 |
| | 2026 | 2024 | SANTE QUEBEC CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 SAINT-DENIS STREET | MONTREAL | QC | | | CAN | R01EY030838 | Retinal Ganglion Cell Dendrite and Synapse Regeneration in Glaucoma: the Role of Insulin Signaling. | 000 | 5 | NIH | 7/14/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $3,504,046 ) |
| | 2025 | 2025 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTRAAL | QC | | | CAN | R01EY036865 | Interpericyte tunneling nanotubes as new therapeutic targets for neurovascular recovery and vision restoration in glaucoma. | 000 | 1 | NIH | 9/26/2025 | $2,674,763 |
| | 2025 | 2025 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTRAAL | QC | | | CAN | R01AG054324 | Role of IL-32 as a predictor and mediator of Premature Aging Phenotypes(PAP) in HIV infection. | 000 | 9 | NIH | 8/6/2025 | $829,283 |
|
| Issue Date FY: 2024 ( Subtotal = $935,144 ) |
| | 2024 | 2024 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTRAAL | QC | | | CAN | R01AG054324 | Role of IL-32 as a predictor and mediator of Premature Aging Phenotypes(PAP) in HIV infection. | 000 | 8 | NIH | 5/23/2024 | $427,996 |
| | 2024 | 2024 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTRAAL | QC | | | CAN | R01EY030838 | Retinal Ganglion Cell Dendrite and Synapse Regeneration in Glaucoma: the Role of Insulin Signaling. | 000 | 5 | NIH | 7/1/2024 | $507,148 |
|
| Issue Date FY: 2023 ( Subtotal = $1,043,135 ) |
| | 2023 | 2023 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTREAL | PQ | | | CAN | R01AG054324 | Role of IL-32 as a predictor and mediator of Premature Aging Phenotypes(PAP) in HIV infection. | 001 | 7 | NIH | 5/10/2023 | $433,719 |
| | 2023 | 2023 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTREAL | PQ | | | CAN | R01EY030838 | Retinal Ganglion Cell Dendrite and Synapse Regeneration in Glaucoma: the Role of Insulin Signaling. | 000 | 4 | NIH | 5/30/2023 | $609,416 |
| | 2023 | 2020 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTRAAL | QC | | | CAN | R01DK058096 | HB-EGF as a central regulator of pancreatic beta-cell proliferation | 000 | 17 | NIH | 12/7/2022 | $0 |
| | 2023 | 2020 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTRAAL | QC | | | CAN | R01AG054324 | Role of IL-32 as a predictor and mediator of Premature Aging Phenotypes(PAP) in HIV infection. | 000 | 5 | NIH | 4/25/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $1,030,506 ) |
| | 2022 | 2022 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTREAL | PQ | | | CAN | R01AG054324 | Role of IL-32 as a predictor and mediator of Premature Aging Phenotypes(PAP) in HIV infection. | 000 | 6 | NIH | 7/27/2022 | $439,372 |
| | 2022 | 2022 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTREAL | PQ | | | CAN | R01EY030838 | Retinal Ganglion Cell Dendrite and Synapse Regeneration in Glaucoma: the Role of Insulin Signaling. | 000 | 3 | NIH | 5/25/2022 | $591,134 |
|
| Issue Date FY: 2021 ( Subtotal = $591,133 ) |
| | 2021 | 2021 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTREAL | PQ | | | CAN | R01EY030838 | Retinal Ganglion Cell Dendrite and Synapse Regeneration in Glaucoma: the Role of Insulin Signaling. | 000 | 2 | NIH | 7/13/2021 | $591,133 |
|
| Issue Date FY: 2020 ( Subtotal = $1,267,158 ) |
| | 2020 | 2020 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTREAL | PQ | H2X 0A9 | | CAN | R01AG054324 | Role of IL-32 as a predictor and mediator of Premature Aging Phenotypes(PAP) in HIV infection. | 000 | 5 | NIH | 6/29/2020 | $438,200 |
| | 2020 | 2020 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTREAL | PQ | H2X 0A9 | | CAN | R01EY030838 | Retinal Ganglion Cell Dendrite and Synapse Regeneration in Glaucoma: the Role of Insulin Signaling. | 000 | 1 | NIH | 5/20/2020 | $607,276 |
| | 2020 | 2020 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTREAL | PQ | H2X 0A9 | | CAN | R01DK058096 | HB-EGF as a central regulator of pancreatic beta-cell proliferation | 000 | 17 | NIH | 6/25/2020 | $221,682 |
|
| Issue Date FY: 2019 ( Subtotal = $621,093 ) |
| | 2019 | 2019 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTREAL | PQ | H2X 0A9 | | CAN | R01AG054324 | Role of IL-32 as a predictor and mediator of Premature Aging Phenotypes(PAP) in HIV infection. | 000 | 4 | NIH | 6/1/2019 | $399,411 |
| | 2019 | 2019 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTREAL | PQ | H2X 0A9 | | CAN | R01DK058096 | HB-EGF as a central regulator of pancreatic beta-cell proliferation | 000 | 16 | NIH | 6/25/2019 | $221,682 |
| | 2019 | 2015 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTREAL | PQ | H2X 0A9 | | CAN | R01HL092565 | Immunoregulatory networks and HIV pathogenesis | 001 | 9 | NIH | 9/30/2019 | $0 |
| | 2019 | 2014 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTREAL | PQ | H2X 0A9 | | CAN | R01HL092565 | Immunoregulatory networks and HIV pathogenesis | 000 | 8 | NIH | 8/29/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $656,656 ) |
| | 2018 | 2018 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTREAL | PQ | H2X 0A9 | | CAN | R01DK058096 | HB-EGF as a central regulator of pancreatic beta-cell proliferation | 000 | 15 | NIH | 6/4/2018 | $221,682 |
| | 2018 | 2018 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTREAL | PQ | H2X 0A9 | | CAN | R01AG054324 | Role of IL-32 as a predictor and mediator of Premature Aging Phenotypes(PAP) in HIV infection. | 000 | 3 | NIH | 6/14/2018 | $434,974 |
| | 2018 | 2015 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 850 RUE SAINT-DENIS | MONTREAL | PQ | H2X 0A9 | | CAN | R21AI113096 | TILDA: A new sensitive and precise assay to measure the size of the latent HIV reservoir | 000 | 3 | NIH | 11/29/2017 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $617,307 ) |
| | 2017 | 2017 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 3840 RUE SAINT-URBAIN | MONTREAL | PQ | H2W 1T8 | | CAN | R01DK058096 | HB-EGF as a central regulator of pancreatic beta-cell proliferation | 000 | 14 | NIH | 6/26/2017 | $221,682 |
| | 2017 | 2017 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 3840 RUE SAINT-URBAIN | MONTREAL | PQ | H2W 1T8 | | CAN | R01AG054324 | Role of IL-32 as a predictor and mediator of Premature Aging Phenotypes(PAP) in HIV infection. | 000 | 2 | NIH | 7/5/2017 | $395,625 |
| | 2017 | 2015 | CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL | 3840 RUE SAINT-URBAIN | MONTREAL | PQ | H2W 1T8 | | CAN | R01HL092565 | Immunoregulatory networks and HIV pathogenesis | 000 | 9 | NIH | 6/29/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $433,867 ) |
| | 2016 | 2016 | UNIVERSITY OF MONTREAL HOSPITAL | 3840 ST URBAIN STREET | MONTREAL, QUEBEC | | | | CAN | R01AG054324 | Role of IL-32 as a predictor and mediator of Premature Aging Phenotypes(PAP) in HIV infection. | 000 | 1 | NIH | 9/27/2016 | $433,867 |
|
| Issue Date FY: 2015 ( Subtotal = $741,398 ) |
| | 2015 | 2015 | UNIVERSITY OF MONTREAL HOSPITAL | 3840 ST URBAIN STREET | MONTREAL, QUEBEC | | | | CAN | R01DK058096 | HB-EGF as a central regulator of pancreatic beta-cell proliferation | 000 | 12 | NIH | 7/10/2015 | $15,552 |
| | 2015 | 2015 | UNIVERSITY OF MONTREAL | 3850 RUE SAINT-URBAIN | MONTREAL, QUEBEC | | | | CAN | R01HL092565 | Immunoregulatory networks and HIV pathogenesis | 000 | 9 | NIH | 5/13/2015 | $265,950 |
| | 2015 | 2015 | UNIVERSITY OF MONTREAL HOSPITAL | 3840 ST URBAIN STREET | MONTREAL, QUEBEC | | | | CAN | R21AI113096 | TILDA: A new sensitive and precise assay to measure the size of the latent HIV reservoir | 002 | 3 | NIH | 7/16/2015 | $162,000 |
| | 2015 | 2015 | UNIVERSITY OF MONTREAL HOSPITAL | 3840 ST URBAIN STREET | MONTREAL, QUEBEC | | | | CAN | R01DK058096 | HB-EGF as a central regulator of pancreatic beta-cell proliferation | 001 | 13 | NIH | 7/15/2015 | $212,616 |
| | 2015 | 2014 | UNIVERSITY OF MONTREAL HOSPITAL | 3840 ST URBAIN STREET | MONTREAL, QUEBEC | | | | CAN | R21AI113096 | TILDA: A new sensitive and precise assay to measure the size of the latent HIV reservoir | 001 | 2 | NIH | 2/20/2015 | $85,280 |
|
| Issue Date FY: 2014 ( Subtotal = $477,216 ) |
| | 2014 | 2014 | UNIVERSITY OF MONTREAL | 3850 RUE SAINT-URBAIN | MONTREAL, QUEBEC | | | | CAN | R01HL092565 | Immunoregulatory networks and HIV pathogenesis | 000 | 8 | NIH | 7/22/2014 | $264,600 |
| | 2014 | 2014 | UNIVERSITY OF MONTREAL HOSPITAL | 3840 ST URBAIN STREET | MONTREAL, QUEBEC | | | | CAN | R01DK058096 | HB-EGF as a central regulator of pancreatic beta-cell proliferation | 000 | 12 | NIH | 6/12/2014 | $212,616 |
|
| Issue Date FY: 2013 ( Subtotal = $462,216 ) (Continued on the next page) |
| | 2013 | 2013 | HOTEL-DIEU HOSPITAL MONTREAL | 3840 ST URBAIN STREET | MONTREAL, QUEBEC | | | | CAN | R01DK058096 | HB-EGF as a central regulator of pancreatic beta-cell proliferation | 000 | 11 | NIH | 6/20/2013 | $205,176 |
|
